Multiple RNA splicing sites exist within human immunodeficiency virus type 1 (HIV-1) genomic RNA, and these sites enable the synthesis of many mRNAs for each of several viral proteins. We evaluated the biological significance of the alternatively spliced mRNA species during productive HIV-1 infections of peripheral blood lymphocytes and human T-cell lines to determine the potential role of alternative RNA splicing in the regulation of HIV-1 replication and infection. First, we used a semiquantitative polymerase chain reaction of cDNAs that were radiolabeled for gel analysis to determine the relative abundance of the diverse array of alternatively spliced HIV-1 mRNAs. The predominant rev, tat, vpr, and env RNAs contained a minimum of noncoding sequence, but the predominant nef mRNAs were incompletely spliced and invariably included noncoding exons. Second, the effect of altered RNA processing was measured following mutagenesis of the major 5' splice donor and several cryptic, constitutive, and competing 3' splice acceptor motifs of HIV-1NL4-3. Mutations that ablated constitutive splice sites led to the activation of new cryptic sites; some of these preserved biological function. Mutations that ablated competing splice acceptor sites caused marked alterations in the pool of virus-derived mRNAs and, in some instances, in virus infectivity and/or the profile of virus proteins. The redundant RNA splicing signals in the HIV-1 genome and alternatively spliced mRNAs provides a mechanism for regulating the relative proportions of HIV-1 proteins and, in some cases, viral infectivity.
Eucaryotic cells control their metabolic activities by regulating gene promoter activity and the processing of RNA and protein. In the same way that the study of viral promoters has served as a paradigm for the promoters of their host mammalian cells, the investigation of viral RNA processing in mammalian cells has provided an insight into various mechanisms used to regulate the steady-state level of a specific mRNA. The complex nature of the processing of human immunodeficiency virus type 1 (HIV-1) RNAs provides an important model for human RNA processing pathways. All retroviruses require RNA splicing to remove upstream gag and pol coding sequences from the env mRNA. In addition, HIV-1 generates a distinctly complex pattern of spliced RNA to encode the essential regulatory proteins, Tat and Rev, as well as several other proteins (Vif, Vpr, and Nef) needed for successful replication in vivo (3, 15, 18, 26, 32, 35, 36, 43, 47, 52) . The HIV-1 Rev protein binds viral RNA species that contain the Rev-responsive element (RRE), located in the env gene, thereby promoting the export, and possibly the stability and translation, of partially spliced and unspliced RNAs from the nucleus into the cytoplasm for its translation and/or packaging into progeny virions (2, 6, 7, 9, 12-14, 19, 20, 22, 23, 28, 33, 36, 38) . The Rev-RRE system alleviates the paradoxical requirement for both spliced and unspliced HIV-1 RNA for successful virus replication. Rev protein also regulates the temporal change from multiply spliced HIV-1 RNAs to partially spliced or unspliced RNAs during productive virus infection (27, 29) .
The splicing of HIV-1 RNA is extremely complex because of the presence of both constitutive and alternatively used 5 (17, 34) .
We exploited the self-replicating capacity of HIV-1 to examine the role of alternative RNA 
MATERIALS AND METHODS
Construction of proviral mutants. The HIV-1 proviral molecular clone pNL4-3 was constructed from the NY5 and LAV (LAI) HIV-1 isolates (1) . A PCR-based mutagenesis protocol that used a mutagenic oligonucleotide and a second primer positioned near a convenient restriction endonuclease site was used to generate a PCR product containing the mutation. This product was gel purified and used as a megaprimer with a third oligonucleotide positioned near a second convenient restriction site to generate DNA containing the mutated splice site and the two restriction sites (31) . These products were cloned into the pCR1000 vector (Invitrogen, San Diego, Calif.), screened by restriction mapping, and then cloned back into the HIV-1 provirus by using the selected restriction sites. The oligonucleotides used, with mutated nucleotides underlined, were as follows: for SD1, Odp.008 (5'-TGGCGTACTCTGC AGTCGCCGCC-3') with Odp.002 (5'-CTCTGGTAACTAG AGATCCCTCAG-3') and then Odp.007 (5'-CTCATCTGGC CTGGTGCAATAAGG-3'); for SA4b, Odp.023 (5'-AGGAG ATGCTCAAGGC7lITYlGTCATG-3'), and for SA5, Odp.025 (5'-GTCTCCGCTTlCTTCGAGCCATAGG-3'), each with Odp.021 (5'-GAATTGGGTGTCGACATAGCAG-3') and then Odp.030 (5'-TTGFLT7AYTATTATlTTCCAAATTGTTC TC-3'); for SA6, Odp.028 (5'-GTGTTAGYTTATCTTG CACTGATTTGAAG-3') with Odp.030 and then Odp.021; and for SA7a, Odp.033 (5'-CTATAGTGAATTCAGTTAG GCAGGGAT-3'), for SA7a+7b, Odp.035 (5'-CTATAGT GAATTCAGTlTlTCGCAGGGATATT-3'), and for SA7,7a, 7b, Odp.037 (5'-CTATAGTGAATTCAGFT[TCGCAGGGA TATTCACCATTATCGT'Tl7CGTACCCACCTCCCCTATA GTG AA T A GA GTTAG G CAGGGATAT-3'), each with Odp.032 (5'-CCGCAGATCGTCCCAGATAAG-3') and then Odp.031 (5'-AGTAGAGCAAAATGGAATGCCAC-3'). (Fig. lD) ; the second specifically analyzed the larger 4.0-kb RNA species, which contain exons that extend beyond SD4 into the env reading frame (vpu/env, one-exon tat, vpr, and viJf), by using the Odp.045 and Odp.070 primers (Fig. IE) . Representative gels, depicting the PCR products that resulted from random hexamer priming of the multiple species of HIV-1 RNA present in infected PBMC prior to the peak of RT production, are shown in Fig. 1D and E. Each of these cDNA bands was excised from the gel, reamplified, and directly sequenced. Several representative cDNA clones of each band were also introduced into the pCRII vector, which contains a T7 promoter adjacent to the cloning site, and also sequenced. To ascertain whether the relative quantity of the PCR-amplified cDNA bands visualized on the gel faithfully represented the relative levels of the various RNA species isolated from infected cells, plus-sense HIV-1 RNA was synthesized from eight different cDNA clones in vitro by using T7 RNA polymerase, directly quantified, and then mixed in known proportions. Included among these RNAs was one, designated cryptic, from a cDNA clone containing exons 1, 2x, 5, and 7, where exon 2x reads through SD2 to a cryptic SD at position 5059 in vif. The RNA mixtures were then used as templates for cDNA synthesis and PCR amplification, and the -P-labeled PCR products generated were analyzed by phosphoimaging (Fig. 2) . We found that the proportion of radioactivity measured for each cDNA band closely matched the proportion of RNA added to the mixture prior to cDNA synthesis ( Fig. 2A) . Thus 4-ih: 6: 1D) , and three novel vpulenv mRNAs, env4, env9, and envl6 (Fig. 1E ). The SA4c site is 18 nucleotides (nt) upstream from SA4a and is conserved among most, but not all, HIV-1 isolates (Fig. 3) . The SA4c splice site exists in HIV-lHXB2, HIV-1LAI, HIV-lJR-CsF, and HIV-lBA-L, the strains used in earlier studies mapping the splicing motifs of HIV-1, although its use was not noted (3, 15, 18, 35, 43, 47) . Since no new translation initiation sites are introduced into mRNAs using SA4c, transcripts containing exons 4c and 4cE would still encode typical HIV-1 Rev or Env protein. However, structural changes introduced into these mRNAs may affect their translatability. An ATG codon exists in the HIV-1NL43 between SA4c and SA4a but is present in a context unfavorable for efficient translation (30) .
Relative abundance of the alternatively spliced HIV-1 mRNAs. Since PCR amplification of HIV-1 cDNA preserved the relative proportion of the various alternatively spliced forms of HIV-1 RNA, we used phosphoimaging analysis to directly determine the relative abundance of each of these RNAs in a spreading HIV-1NL4-3 infection of PBMC ( Fig. 2 and 4). Within the 1.8-kb class of HIV-1 mRNAs (Fig. 4A) , nef, rev, tat, and vpr species existed in a ratio of 56:34:9:1; within the 4.0-kb class (Fig. 4B) , env, tat, vpr, and vif species existed in a ratio of 92:5:2:1. Of the nef mRNAs, nef2, which includes noncoding exon 5 flanked by SA5 and SD4, was the predominant type, comprising 49% of all nef RNA and 28% of all 1.8-kb RNAs. nef RNAs containing noncoding exon 3 (nef4) or 2 (nef3) or both 2 and 3 (nef5) were present in decreasing amounts. Nefl RNA, which lacks a noncoding exon, was the least abundant nef mRNA. It is unclear whether the nontranslated RNA from exon 5 contributes to nef function, as the nef gene has not been evaluated as an RNA element, only as protein.
In contrast, the predominant spliced mRNAs for the other HIV-1 proteins lacked noncoding exons. Only 20% of rev mRNA includes a noncoding exon, and the use of noncoding exon 3 (rev7, rev8, and rev9) or both exons 2 and 3 (revl0, revll, and revl2) predominates over use of exon 2 alone (rev4, revS, and rev6). In addition, revl and rev2 mRNAs, utilizing SA4a and SA4b, respectively, occur approximately fivefold more frequently than rev3 mRNA, which uses the previously unreported SA4c. Both the one-and two-coding-exon forms of tat mRNA (1.8-and 4.0-kb class RNAs, respectively) infrequently use noncoding exons 2 and 3 (tatl and tat5). However, when a tat mRNA contained a noncoding exon, exon 2 was predominantly used (tat2 and tat6). The relative proportion of the one-and two-exon forms of tat or vpr mRNA could not be determined here, since the assays for the 1.8-and 4.0-kb mRNAs are merely semiquantitative among the species represented in each PCR assay.
Eighty percent of env mRNAs use SA5 (exon SE); however, 12% of env RNAs (env2, env3, and env4) utilize the upstream SA4a, SA4b, or SA4c (exon 4aE, 4bE, or 4cE) when noncoding exons 2 and 3 were excluded. Noncoding exons 2 and 3 were used only at low (<5%) frequency in env mRNA and mostly in conjunction with SA5 (envS, env8, and envl3). This study clearly identifies mRNA species containing both noncoding exons 2 and 3 in the same transcript. This finding contrasts with previous analyses of RNA directed by the HIV-lHXB2 strain that identified these as mutually exclusive exons (15, 18, 47) but is in agreement with a recent report that characterized viral (35) . Exons represented by gray bars were not found in any of the RNA species examined in these studies. Exons (15, 48, 49) . (E) Representative acrylamide gel from PCR analysis of HIV-1 mRNA species falling into the 4.0-kb size range from pNL4-3-infected PBMC, using primers Odp.045 and Odp.070 (positions 6094 to 6115). The identity of each RNA species, determined by direct sequence analysis of excised bands, is shown with the exon content and size of the PCR product. RNA species not matched to a band on the gel were difficult to detect except on very long gel exposures and were not quantified above the background level in phosphoimaging analysis. All env mRNAs are multicistronic and also encode Vpu and Nef (48, 49 amplified species is shown on the right (see Fig. 1D ). Splice site mutants of pNL4-3. During HIV-1 mRNA splicing, the cellular spliceosome cleaves at GT and AG dinucleotides within the SD and SA motifs, respectively. Several of these highly conserved dinucleotide motifs present in the pNL4-3 proviral DNA clone of HIV-1 were replaced with different dinucleotides to block RNA splicing, using a PCRbased strategy (Fig. 5) . Seven site-directed provirus mutants were generated by inactivating (i) the constitutively used major splice donor, pNLASD1; (ii) the competing splice acceptor for the first coding exon of rev, pNLASA4b; (iii) the competitively selected major splice acceptor for env and vpu, pNLASA5; (iv) the cryptic splice acceptor within env purportedly used to generate the Tev protein (5, 46, 47), pNLASA6; (v) SA7a, the most 5' of two conserved cryptic SA sequences mapping 34 Protein synthesis by splicing mutants of HIV-1. In the first group of experiments, the effects of the splice site mutations on viral protein production were assessed by Western blotting (immunoblotting) lysates from transfected HeLa cells, using an AIDS patient's serum. As shown in Fig. 6 , each of the mutants except pNLASA7+7a+7b directed the synthesis of the same complement of HIV-1 proteins as did wild-type pNL4-3, with the following exceptions. Mutation of SD1 caused a marked decrease in the quantity of viral proteins accumulating in HeLa cells during the first 48 h despite transfection efficiency equivalent to that of the wild type, as measured by coexpression of a human growth hormone expression plasmid (Fig. 6A, lanes 1  and 2) . By 72 h after transfection, however, HIV-1 protein accumulation directed by mutant plasmid pNLASD1 was comparable to the wild-type level (Fig. 6B, lanes 1 and 2) . Mutation of SA4b, used for the production of rev and env mRNAs, led to consistent and substantial elevations of gpl60/120 levels compared with the wild type (Fig. 6A, lane 3) . In contrast, the mutation of SA5 markedly reduced, but did not eliminate, gpl60/120 production (Fig. 6A, lane 4) . Mutation of SA6 (for tev mRNA) and the SA7a or SA7a+7b cryptic splice sites (for the second coding exon of tat and rev) had little if any effect on HIV-1 protein synthesis (Fig. 6A, lanes 5 to 7) , indicating that these three SA sites (and exons 6, 7a, and 7b) play no significant role for HIV-1 protein synthesis in transfected HeLa cells. In contrast, mutant pNLzASA7+7a+7b, which contains a triple splice site mutation including SA7, the in-frame acceptor used constitutively for the second coding exon of tat and rev, directs the synthesis of a markedly altered protein profile (Fig. 6A, lane 8) , similar to that previously reported for Rev-deficient HIV-1 mutants: minimal levels of p55, p24, or pl7gag protein and no detectable gpl60/120 (12, 14, 20, 33) accompanied by a novel and abundant 20- (Fig. 7) . For example, mutants pNLASA6, pNLASA7a, and pNLASA7a+7b were indistinguishable from the wild type (Fig. 7, lanes 7 to 9) , indicating that the SA6, SA7a, and SA7b sites are not used with significant frequency by HIV-1NL43, even though it is virtually identical to HIV-lHXB2, the strain in which these splice sites were originally described. Furthermore, no cDNAs using the SA6, SA7a, or SA7b splice site were ever detected among the PCR-amplified bands that were directly sequenced from cells transfected or infected with derivatives of HIVLAI or HIV-lN"-3, and no clone generated from these PCR-amplified cDNAs could be shown to utilize these splice sites. Thus, the SA6, SA7a, and SA7b cryptic sites are used extremely rarely, if at all, and may be active only in the HIV-1LAI derivative HIV-lHxB2.
We found that careful selection and testing of PCR primers was required, in conjunction with the use of poly(A)+ RNA and nonspecific cDNA priming, to avoid the amplification of aberrant cDNAs. Our semiquantitative PCR assays depended on equal use of all the HIV-1 RNA species in either the 1.8-or 4.0-kb mRNA classes as competing templates for amplification. Other protocols may selectively amplify transcripts using SA6, SA7a, and SA7b (47) quence of cDNA clones around the SA7 splice site (15) or using hybridization analyses of cDNAs (50) also failed to detect usage of SA7a or SA7b.
Analysis of mRNA from HIV-1 with mutated constitutive and competitive splice sites. The cDNAs amplified from cells transfected with mutant pNLASD1 had a pattern very similar to that of the wild type but with a slightly slower electrophoretic mobility (compare lanes 3 and 4 in Fig. 7) . Direct sequence analysis of these PCR bands as well as several individual cDNA clones indicated that spliced RNA from pNLASD1 used a GT dinucleotide 4 nt downstream from the mutated major SD (constitutive SD1) site as a cryptic SD site in this HIV-1 proviral DNA. The HIV-1 proteins translated from these slightly larger mRNAs were indistinguishable from the wild type (Fig. 6 ), but the rate of splicing of these viral transcripts may be slower, perhaps explaining the delay in protein expression previously observed. This cryptic SD (incorrectly annotated as the major SD in the alignment of this region by Myers et al. [37] ) is strongly conserved among all HIV-1 isolates. Because the cryptic SD1 site may be used only when the genuine site is inactivated, it is likely that the strong conservation of this alternative splice site results from additional selective pressures. Nevertheless, its existence greatly reduces the possible loss of virus infectivity due to a spontaneous mutation affecting the major SD that would otherwise block the production of functional spliced mRNAs.
The cDNAs amplified from the remaining mutants differed from the pNL4-3 wild-type pattern ( Fig. 7 and 8 ). For the provirus mutant inactivating the constitutive SA7 for the second coding exon of tat and rev, pNLASA7+7a+7b, every cDNA band clearly differed in size compared with the wild type following amplification of the 1.8-kb species of HIV-1 mRNA (Fig. 8A, lane 4) ; the overall pattern was similar to the wild-type pattern except that each band had a faster electrophoretic mobility. A direct sequence analysis of these PCR bands and sequencing of individual pNLASA7+7a+7b cDNA clones indicated that all used an AG dinucleotide situated 20 nt downstream from SA7 as the alternative SA site; this resulted in cDNAs that were 20 bases shorter than the wild type. The activation of this cryptic downstream SA site, however, precluded the generation of mRNA capable of encoding a functional Rev protein and resulted in an immunoblot devoid of HIV-1 structural proteins (Fig. 6A, lane 8) . It should be noted that all of the wild-type 1.8-kb spliced RNAs were transcribed as truncated species by mutant pNLA SA7+7a+7b except for the nefl RNA, which was not detected on the autoradiogram shown in Fig. 8A . The cDNA bands obtained for pNLASA7+7a+7b after PCR for the 4.0-kb mRNA were identical to those of wild-type virus, indicating that RNA splicing to SA and SD sites upstream of SA7 was not affected by the absence of functional two-exon Rev protein. This finding demonstrates that Rev is not required for splice site selection in HIV-1 RNAs; however, protein expression from RNAs containing an RRE clearly requires functional Rev protein.
Mutation of each of two competing SA sites, SA4b and SA5, caused a different usage frequency for neighboring SA sites but not the activation of any cryptic sites. The first competing SA mutant, pNLASA4b, failed to generate bands for revl (Fig. 8A , lane 2), rev4, rev7, and revlO (evident after long gel exposures; not shown) following PCR with primers for the 1.8-kb mRNA species and for env2 (Fig. 8B, lane 2) , env6, envlO, and envl4 (evident after long gel exposures; not shown) after PCR with primers for the 4.0-kb mRNA. The failure to detect these bands was consistent with the absence of RNAs splicing to the mutagenized SA4b site. All other cDNAs amplified from pNLASA4b were identical to wild-type cDNAs. The cDNA pattern associated with the second competing SA mutant, pNLASA5, lacked several predominant nef species (nef2, nef3, nef4, and nef5) after PCR for the 1.8-kb mRNA (Fig. 8A, lane  3) , as well as the major env species (envl, env5, env8, and envl3) after PCR for the 4.0-kb mRNA (Fig. 8B, lane 3) , reflecting the absence of RNAs splicing to the mutagenized SA5 site. In addition, there was a compensatory increase in the use of SA4, SA4a, SA4b, and SA4c, resulting in increased levels of revl, rev2, rev3, tatl, tat2, tat3, tat4, tat5, tat6, tat7, env2, env3, and env4 mRNAs.
Translational consequences of altered RNA profile for competitive splice site mutants. Since the mRNAs using the competing SA4a, SA4b, SA4c, and SA5 splice sites are multicistronic, potentially coding several proteins from each mRNA (15, 48, 49) , we examined the effect of altered proportions of HIV-1 mRNAs on protein expression (Fig. 9) . Mutant pNLAiSA4b directed the synthesis of a significantly increased level of envelope gpl60/120 and Nef but decreased amounts of Rev compared with wild-type provirus (Fig. 9A to C, lanes 3) . Because Rev protein plays a prominent role in regulating the level of gpl60/120, we evaluated Rev functional activity by measuring the Rev-dependent rescue of CAT activity following cotransfection of pNLASA4b with the pDM128 Rev reporter plasmid ( Fig. 9E and F) (24) . Again, Rev activity directed by pNLASA4b, as measured in this assay, was lower than that directed by wild-type pNL4-3. Thus, the observed elevation of gpl60/120 was not due to any increase in Rev activity. Significantly, the expression of both Rev-dependent gpl60/120 and Rev-independent Nef proteins were increased in similar proportions. These proteins share SA5 as the predominant competing SA for their mRNAs. Thus, the increased synthesis of gpl60/120 and Nef from the pNLASA4b mutant most likely reflects the increased use of SA5 (and SA4c) and results in increased synthesis of both proteins. This occurs despite the loss of mRNA species using SA4b which encode Rev. Since increased use of SA4c does not prevent the reduction of Rev expression, if is likely that multicistronic mRNAs using SA4c are less efficient for Rev expression than for Nef or gpl60/120 expression.
HeLa cells transfected with pNLASA5 express very low levels of gpl60/120 and Nef proteins but elevated levels of Rev compared with wild-type pNL4-3 ( Fig. 9A to C, lanes 4) . Elevated Rev activity was also measured in the assay of Rev-dependent rescue of CAT activity, showing that the low level of gpl60/120 expression did not result from any deficiency in Rev function. The low-level expression of gpl60/120 most likely results from the inefficient translation of the multicistronic env2, env3, and env4 mRNAs, which are present at relatively increased levels in cells transfected with pNLASA5 compared with the wild-type pNL4-3 (Fig. 8B, lanes 1 and 3) . This result indicates that the multicistronic env mRNAs are markedly less competent for gpl60/120 expression than is envl. pNLASA5 also fails to synthesize the major nef RNAs (nef2, through nef5; Fig. 4) , although the levels of the nefl cDNA species, which results from splicing of SD1 directly to constitutive SA7, were equivalent in the pNLASA5-and wild-typetransfected cells (Fig. 8A) . This low expression of Nef protein indicates that the increased amount of bicistronic revinef and envinef mRNAs encoded by mutant pNLASA5 fails to compensate for the loss of the predominant monocistronic nef mRNAs. The elevated levels of Rev protein observed demonstrate that the bicistronic revinef and envinef mRNAs encode Rev with significantly higher efficiency than Nef.
Infectivity of splicing mutants of HIV-1. The ability of the HIV-1 splice site mutants to generate progeny virions was assessed by measuring the RT activity released into the medium following cotransfection of HeLa cells with proviral and human growth hormone DNAs (Fig. 10A) . All of the splice site mutants except pNLASA7a+7b generated less particle-associated RT than did the wild-type plasmid pNL4-3; pNLASA7+7a+7b and pNLASD1 produced only 2 and 15% of viral progeny, respectively, compared with the wild type.
The infectivity of the splice site mutants was evaluated by inoculating CEM (12D7) cells with equal amounts of virus harvested from transfected HeLa cell supernatants as determined by RT assay (for wild-type pNL4-3, the multiplicity of infection was approximately 0.002) (Fig. lOB) . Spreading infection was established by one of the two proviruses containing a mutated constitutive site. Mutant pNLASD1 was infectious but exhibited delayed replication kinetics compared with wildtype pNL4-3, reflecting the delayed kinetics of protein synthesis by this mutant (Fig. lOB) . Lower efficiency of RNA splicing from the cryptic donor activated in pNLASD1 is very likely responsible for the delayed replication and infectivity kinetics.
Mutant pNLASA7+7a+7b, which lacks the constitutive SA7 site, could not infect CEM (12D7) cells, reflecting its inability to produce Rev and the HIV-1 structural proteins.
Mutations affecting competing SA sites in HIV-1 had different effects on viral infectivity. Mutant pNLASA4b, which fails to generate several HIV-1 mRNAs (revl, rev4, rev7, and revlO and env2, env6, envlO, and envl4) and consistently expressed elevated levels of gpl60/120, exhibited growth kinetics similar to the wild-type virus kinetics (Fig. lOB) . In this case, altered splicing of viral mRNA had no effect on viral infectivity. Mutant pNLASA5, which lacks the processing site for the major envl mRNA species, was not infectious despite being able to synthesize low levels of gpl60/120 in transfected HeLa cells by utilizing alternative SAs (Fig. 6A, lane 4; Fig. 9A (Fig. 6 and 7 ). These latter results could indicate that the cryptic SA6 and SA7b sites participate in some other aspect of RNA processing (e.g., folding or branch point formation). Alternatively, amino acid changes introduced into the envelope protein as a result of mutagenesis '(see Materials and Methods) may eliminate virus infectivity, possibly by affecting gpl60 processing as suggested by reduced amounts of gpl20 observed in Fig. 6A . In a previous study, a similar mutation of SA6 in the HIV-lHXB2 isolate resulted in the loss of infectivity, whereas SD5 mutants, also defective for Tev expression, had a wild-type phenotype (16) . (Fig. 3) (15, 47) . Some of the splice site mutants described above selectively eliminate several of these mRNAs from the HIV-1 RNA pool, allowing an evaluation of these depleted transcripts in the context of virus replication. The inactivation of SA5 from provirus mutant pNLASA5 precluded the synthesis of the major species of env mRNA (envl) as well as the predominant nef mRNAs (nef2 through nef5). During productive infection of PBMC with wild-type HIV-1, envl and nef2 through nef5 mRNAs comprise 80% of the total env and 95% of the total nef transcripts, respectively. Intuitively, the elimination of these mRNAs could be compensated for by the increased use of other neighboring SAs which could be used to synthesize alternate multicistronic mRNAs with coding potential for the deficient Env and Nef proteins. Our analyses showed that multicistronic mRNAs generated only limited amounts of Nef and gpl60/120 proteins which proved inadequate for the production of infectious progeny virion. After transfection of HeLa cells with mutant pNLL\SA5, minimal synthesis of gpl60/120 (-2% of the wild-type level) and low levels of Nef (-12% of the wild-type level) were measured. In our studies, bicistronic rev mRNAs encoded Nef protein with 2-to 3-fold-lower efficiency than did monocistronic nef mRNAs (in agreement with results of Schwartz et al. [49] ) and gpl60/120 was translated from envl mRNA approximately 25-fold more efficiently than from other env mRNAs. Given the proportions of the different HIV-1 mRNAs measured in this study, neither multicistronic env RNA containing the Rev, Vpu, and Env translation initiation sites (env2 through env5) nor the multicistronic rev RNA species, also capable of directing the synthesis of Nef (15, 47) , significantly contributes to the total cellular pool of gpl60/120 or Nef proteins during virus replication. In contrast, a mutation affecting one of the SAs for rev mRNA (SA4b) resulted in rev mRNAs using SA4a and SA4c that fully compensated for altered SA usage and produced wild-type levels of Rev functional activity.
Mutation of constitutive splice sites activates cryptic sites. Mutation of the major SD (SD1) in the pNL4-3 provirus slowed the kinetics of RNA and protein synthesis and the kinetics of a spreading virus infection. An alternative cryptic major SD signal, four bases downstream, was activated. Because the cryptic SDI site may be used only when the genuine site is inactivated, it is likely that the strong conservation of this alternative splice site results from additional selective pressures. Nevertheless, its existence greatly reduces the possible loss of virus infectivity due to a spontaneous mutation affecting the major SD that would otherwise block the production of functional spliced mRNAs. The efficiency of RNA splicing from this cryptic donor ( 3AGA l GUACGCC+7) may be lower than that from the genuine donor site ( 3CUG l G UGAGUA+7) and would therefore be responsible for the exon ; 5 (4) or weakly interacting (t) with Ul, U5, and U6 snRNAs are shown at the bottom.
delayed replication and infection kinetics of mutant pNLASD1. Comparison of these two HIV-1 SD motifs with the adenovirus major late 5' SD (-3GGG I GUGAGUA+7) (Fig.   11 ), used to map nucleotide interactions with U1, U5, and U6 small nuclear RNAs (snRNAs), provides an explanation for the possible lower splicing efficiency of the cryptic SD1 (56) .
The nucleotides at sites of strong interaction between the adenovirus SD and the Ul, US, and U6 snRNAs of the spliceosome are the same for wild-type HIV-1 SD1 but mismatched at several positions for the cryptic HIV-1 SD1, potentially destabilizing the interaction of the cryptic SD1 with the spliceosome (Fig. 11) . The decreased affinity of the cryptic HIV-1 SD with several important spliceosomal snRNAs may explain the delayed infection kinetics of mutant pNLASD1.
Mutation of SA7, in conjunction with SA7a and SA7b, resulted in the expression of aberrant RNA and protein species and the loss of virus infectivity as a consequence of the activation of a downstream cryptic SA site. The use of this latter site shifted the reading frame for the second coding exon of Rev, thereby causing a concomitant loss of Rev function. Despite the apparent lack of expression of functional Rev by mutant pNLASA7+7a+7b, all other HIV-1 SD and SA site usage was equivalent to that of wild-type pNL4-3, indicating that the two-exon Rev protein is not required for the selection of splice sites in HIV-1 RNAs with or without an RRE. However, assembly of the spliceosome may still be required for Rev to activate RNA containing an RRE (6) .
Significance of cryptic splice sites in HIV-1 replication. We found that three previously mapped splice acceptor sites, SA6, SA7a, and SA7b (47), were never used during HIV-1NL4-3 replication in PBMC and HeLa cells and that mutation of these cryptic sites had no apparent effect on HIV-1 RNA or protein synthesis. These sites were unlikely candidates as commonly used ligation points for the synthesis of mature mRNA because HIV-1 isolates, other than derivatives of HIV-lLAI, do not possess the SA6 splicing signal (37) , and the use of SA7a and SA7b sites would preclude the in-frame entry into the second coding exon of rev and tat, leading to the synthesis of novel Rev-Tat-Env chimeric translation products and no functional Rev protein. The ability of mutant pNLASA7a to suc&essfully replicate and infect human cells further demonstrates that this site is not essential in the HIV-1 life cycle. Unexpectedly, mutants pNL/SA6 and pNLASA7a+ 7b were not infectious, suggesting that these sites might play some other role in RNA processing or that the amino acid structure around these mutagenized SAs is critical for infectivity. Mutational analysis of the tev splicing signals (SD5) in the context of HIV-1HIB indicated that Tev was not required for virus infections of CD4+ T-cell lines and activated PBMC.
However, the tev splicing signal (SA6) in HIV-1HIB stabilized neighboring suboptimal splice sites and maintained the balanced proportion of spliced and unspliced RNAs (16) . The tev splicing pattern may be limited to certain derivatives of HIV-1L.A and could have arisen as a result of inefficient splicing signals throughout the primary RNA transcript in this isolate.
In contrast to the uncertain role of cryptic splice sites in HIV-1, changing the usage of the competing splice sites in the center of the HIV-1 genome caused alterations in the proportions of both HIV-1 RNA and protein species, and this affected viral infectivity. Similarly, mutation of the major SD motif markedly reduced the synthesis of viral RNA and protein as well as viral infectivity. Therefore, we have shown that alternative splicing of mature HIV-1 mRNA is yet another potential mechanism for the regulation of HIV-1 expression. Thus, the multiple redundant splice signals in the central region of the HIV-1 genome play a greater role than simply providing redundant strategies for mRNA synthesis in the event of unwanted mutations at these sites.
